CFDE Data Portal | Search LINC02516

	Label	Description
	LINC02516 Gene (Entity type)	ENSG00000261083 - long intergenic non-protein coding RNA 2516
	GSE196035 GSE196037 MEN1 inhibition 8 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE120210 GSE120214 TBXT brachyury inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 paclitaxel R1192 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Kidney 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Breast 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Nerve 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Spleen 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx

LINC02516

ENSG00000261083 - long intergenic non-protein coding RNA 2516

GSE196035 GSE196037 MEN1 inhibition 8 v 10 human dn

A Gene Set from LINCS

GSE120210 GSE120214 TBXT brachyury inhibition 1 v 3 human up

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 3 human dn

A Gene Set from LINCS

GSE228106 paclitaxel R1192 0 v 5 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 13 human dn

A Gene Set from LINCS

GTEx Kidney 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Breast 20-29 vs 70-79 Down

A Gene Set from GTEx

GTEx Nerve 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx Spleen 20-29 vs 70-79 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.